Nov 22, 2019
In this interview, Spencer King and David Fitchett discuss the relationship between hypoglycemia outcomes and empagliflozin treatment in the EMPA-REG OUTOME trial (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients).